Lumira Capital Life Sciences Quarterly Newsletter - Q2, 2010 06/30/2010 Lumira Capital Life Sciences Quarterly Newsletter - Q1, 2010 03/31/2010 Elekta acquires Resonant Medical Inc., adding new solutions for image guided radiation therapy for treating cancer. 05/31/2010 Cephalon Exercises its Option to Acquire Ception Therapeutics for $250 Million 02/22/2010 Lumira Capital Life Sciences Quarterly Newsletter - Q4, 2009 12/31/2009 Lumira Capital Life Sciences Quarterly Newsletter - Q3, 2009 09/30/2009 Lumira Capital Life Sciences Quarterly Newsletter - Q2, 2009 06/30/2009 First Advanced Sensor Assisted Knee Surgery Performed at The Orthopedic Institute at Holy Cross Hospital 08/25/2010 Argos Therapeutics’ Arcelis™ HIV Immunotherapy Demonstrates Significant Reduction in Viral Load and Delay in Viral Rebou... 08/19/2010 Cardiac Dimensions® Announces Presentation of 12-Month Follow-up Data of TITAN™ Trial at European Society of Cardiology ... 08/17/2010 Paper Published in Molecular Therapy Shows Argos Therapeutics' Arcelis™ Immunotherapy Has Potential to Prevent, Treat Di... 08/03/2010 U-Systems Launches www.somoinsightstudy.org, Supporting a Breast Cancer Screening Clinical Study for Women with Dense Br... 07/21/2010 KAI Pharmaceuticals Announces Phase 1 Results of KAI-4169 for the Treatment of SHPT 07/20/2010 Robotics -RIO Robotic Arm Interactive Orthopedic System Recognized with the 2010 Gold Medical Design Excellence Award 06/14/2010 RIO(R) Robotic Arm System by MAKO Surgical Corp. Wins 2010 Gold Medical Design Excellence Award 06/10/2010 Argos Therapeutics Presents Positive Phase II Data for Arcelis Dendritic Cell-based Immunotherapy in Advanced RCC at ASC... 06/08/2010 Cardiovascular Systems Completes Patient Enrollment In COMPLIANCE 360° Clinical Trial 05/24/2010 Argos Therapeutics Presents Phase 2a Data for Arcelis™ HIV Program Demonstrating Positive Impact on Viral Diversity and ... 05/17/2010 Resonant Medical to Deliver Clarity System Through Group Purchasing Agreement with Amerinet 05/12/2010 Argos Therapeutics Presents Transplantation Data for Soluble CD83 Demonstrating its Ability to Induce Immune Tolerance a... 05/04/2010 Pharmasset Announces Results of a 28-day Phase 2a Study with PSI-7977 for the Treatment of Chronic Hepatitis C Infection... 05/04/2010 Cardiovascular Systems Receives Unconditional FDA Approval For ORBIT II Coronary Clinical Trial 04/29/2010 Pharmasset Announces Interim Data from an Ongoing 28-day Phase 2a Study with PSI-7977 for the Treatment of Chronic Hepat... 04/15/2010 Pharmasset Initiates First Time in Human Study of PSI-938 for the Treatment of Hepatitis C 04/08/2010 U-Systems, Inc. Raises $10M in Additional Funding 03/25/2010 Argos Therapeutics Presents New Phase 2a Data on the Impact of Arcelis HIV Program on Viral Genetic Diversity 03/25/2010 Argos Therapeutics Presents Positive Phase 2 Data of its Arcelis™ Personalized Immunotherapy Platform 03/08/2010 Argos Therapeutics Publishes Positive Immune Response, Safety and Manufacturing Data for its Arcelis™ HIV Program in Cli... 03/04/2010 Promotion of Jack Jenuth to Principal. 02/25/2010 Product developed by acquired Lumira Capital portfolio company, Corus, wins FDA approval 02/22/2010 Pharmasset Announces Complete Enrollment of RG7128 Phase 2b Clinical Study 02/17/2010 CSI Recruits First Patient In Calcium 360° Clinical Trial 02/05/2010 Pharmasset Prices Underwritten Offering of Common Stock 01/28/2010 Pharmasset Initiates Phase 2a Trial with PSI-7977, a Chirally Pure Isomer of PSI-7851 01/21/2010 Minnesota’s Cardiovascular Systems gets FDA approval for Phase 2 coronary trial 01/14/2010 New drug a godsend for 9-year-old with rare type of esophagitis 12/31/2009 Lumira portfolio company SkinStore.com Agrees to be Acquired by drugstore.com, inc. 12/28/2009 Lumira Capital Life Sciences Quarterly Newsletter - Q1, 2009 03/31/2009 Lumira Life Sciences Quarterly Newsletter - Q4, 2008 12/31/2008 Lumira Life Sciences Quarterly Newsletter - Q3, 2008 10/20/2008 Lumira Life Sciences Quarterly Newsletter - Q2, 2008 06/30/2008 Lumira Life Sciences Quarterly Newsletter - Q1, 2008 03/31/2008 Cardiac Dimensions® Inc. Announces Closing of $35.5 Million Round of Financing. JJDC & Lumira Capital Co-Lead Round, Pro... 12/18/2007 MDS Capital Corp. announces investment team promotions and changes its name to Lumira Capital Corp. 09/18/2007 Eisai Announces Completion of Acquisition of Morphotek 04/17/2007 MAKO Surgical Corp. Closes $30 Million in Series C Funding 02/07/2007 Ception Therapeutics Raises $63 Million in Series C Financing. 01/29/2007